Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...

Disruptive innovation is the practice of reshaping a market or activity using novel processes and technologies. The idea has been around since the mid-90s, but it only started having a significant ...